Superficial pseudoaneurysms: clinicopathologic aspects and involvement of extracellular matrix proteoglycans.
D000293:Adolescent; D000328:Adult; D000368:Aged; D017541:Aneurysm, False / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D058578:Biglycan; D015415:Biomarkers / Q000032:analysis; D002648:Child; D011508:Chondroitin Sulfate Proteoglycans / Q000032:analysis / Q000378:metabolism; D058575:Decorin; D005109:Extracellular Matrix / Q000737:chemistry / Q000378:metabolism*; D016326:Extracellular Matrix Proteins; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D037181:Lectins, C-Type; D008297:Male; D008875:Middle Aged; D011509:Proteoglycans / Q000032:analysis / Q000378:metabolism*; D013699:Temporal Arteries / Q000378:metabolism / Q000473:pathology*; D017535:Ulnar Artery / Q000378:metabolism / Q000473:pathology; D053675:Versicans
C546884:BGN protein, human; D058578:Biglycan; D015415:Biomarkers; D011508:Chondroitin Sulfate Proteoglycans; C546878:DCN protein, human; D058575:Decorin; D016326:Extracellular Matrix Proteins; D037181:Lectins, C-Type; D011509:Proteoglycans; C508322:VCAN protein, human; D053675:Versicans